Insulin Degludec vs Linaclotide
Head-to-head comparison of Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) and Linaclotide (Linaclotide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Insulin Degludec | Linaclotide |
|---|---|---|
| Category | Diabetes & Metabolic | Gastrointestinal |
| Full Name | Insulin degludec (desB30, acylated ultra-long-acting insulin analog) | Linaclotide |
| Molecular Weight | 6103.9 Da | 1526.8 Da |
| Half-Life | More than 25 hours | Active locally; negligible systemic half-life |
| Amino Acids | 50 | 14 |
| Typical Dose | 0.1-0.2 U/kg once daily | 72-290 mcg once daily |
| Route | Subcutaneous | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 7000 | 1200 |
| Research Status | Approved | Clinical |
Insulin Degludec Benefits
- ✓Ultra-long basal coverage
- ✓Lower day-to-day variability
- ✓Reduced nocturnal hypoglycemia
- ✓Flexible dosing time
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
Insulin Degludec Dosing
Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
Insulin Degludec Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
Research Overview
Insulin Degludec
Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.